-
1
-
-
77949536656
-
Tissue renin-angiotensin-aldosterone systems: Targets for pharmacological therapy
-
Bader M. Tissue renin-angiotensin-aldosterone systems: targets for pharmacological therapy. Annu Rev Pharmacol Toxicol. 2010;50:439-465.
-
(2010)
Annu Rev Pharmacol Toxicol
, vol.50
, pp. 439-465
-
-
Bader, M.1
-
2
-
-
0033208953
-
Role and regulation of the ER chaperone BiP
-
Gething MJ. Role and regulation of the ER chaperone BiP. Semin Cell Dev Biol. 1999;10:465-472.
-
(1999)
Semin Cell Dev Biol
, vol.10
, pp. 465-472
-
-
Gething, M.J.1
-
3
-
-
77955049339
-
Quality and quantity control at the endoplasmic reticulum
-
Hegde RS, Ploegh HL. Quality and quantity control at the endoplasmic reticulum. Curr Opin Cell Biol. 2010;22:437-446.
-
(2010)
Curr Opin Cell Biol.
, vol.22
, pp. 437-446
-
-
Hegde, R.S.1
Ploegh, H.L.2
-
4
-
-
67649970990
-
Processing of peptide and hormone precursors at the dibasic cleavage sites
-
Rholam M, Fahy C. Processing of peptide and hormone precursors at the dibasic cleavage sites. Cell Mol Life Sci. 2009;66:2075-2091.
-
(2009)
Cell Mol Life Sci
, vol.66
, pp. 2075-2091
-
-
Rholam, M.1
Fahy, C.2
-
5
-
-
0034987953
-
Development and application of a biological peptide pump for the study of the in vivo actions of angiotensin peptides
-
PII S0895706101020684
-
Methot D, vanKats JP, Lochard N, Tremblay F, Silversides DW, Reudelhuber TL. Development and application of a biological peptide pump for the study of the in vivo actions of angiotensin peptides. Am J Hypertens. 2001;14:38S-43S. (Pubitemid 32506695)
-
(2001)
American Journal of Hypertension
, vol.14
, Issue.6
-
-
Methot, D.1
VanKats, J.P.2
Lochard, N.3
Tremblay, F.4
Silversides, D.W.5
Reudelhuber, T.L.6
-
6
-
-
0016704799
-
Role of the C-terminal group for the biological activities of angiotensin
-
Rioux F, Park WK, Regoli D. Role of the C-terminal group for the biological activities of angiotensin. Can J Physiol Pharmacol. 1975;53: 383-391.
-
(1975)
Can J Physiol Pharmacol
, vol.53
, pp. 383-391
-
-
Rioux, F.1
Park, W.K.2
Regoli, D.3
-
7
-
-
0015992585
-
Role of the N-terminal amino acid for the biological activities of angiotensin and inhibitory analogues
-
Regoli D, Rioux F, Park WK, Choi C. Role of the N-terminal amino acid for the biological activities of angiotensin and inhibitory analogues. Can J Physiol Pharmacol. 1974;52:39-49.
-
(1974)
Can J Physiol Pharmacol
, vol.52
, pp. 39-49
-
-
Regoli, D.1
Rioux, F.2
Park, W.K.3
Choi, C.4
-
8
-
-
0019418602
-
5]angiotensin II isolated from the skin of the Australian frog Crinia georgiana
-
DOI 10.1021/jm00139a023
-
Khosla MC, Bumpus FM, Yasuhara T, Nakajima T. Synthesis of ala-progly-[ Ile3, Val5]angiotensin II isolated from the skin of the Australian frog Crinia georgiana. J Med Chem. 1981;24:885-887. (Pubitemid 11058881)
-
(1981)
Journal of Medicinal Chemistry
, vol.24
, Issue.7
, pp. 885-887
-
-
Khosla, M.C.1
Bumpus, F.M.2
Yasuhara, T.3
Nakajima, T.4
-
9
-
-
0027330018
-
AT4 receptor binding characteristics: D-amino acid-and glycine-substituted peptides
-
Sardinia MF, Hanesworth JM, Krebs LT, Harding JW. AT4 receptor binding characteristics: D-amino acid-and glycine-substituted peptides. Peptides. 1993;14:949-954.
-
(1993)
Peptides
, vol.14
, pp. 949-954
-
-
Sardinia, M.F.1
Hanesworth, J.M.2
Krebs, L.T.3
Harding, J.W.4
-
10
-
-
0026342911
-
Tissue-specific regulation of the α-myosin heavy chain gene promoter in transgenic mice
-
Subramaniam A, Jones WK, Gulick J, Wert S, Neumann J, Robbins J. Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J Biol Chem. 1991;266:24613-24620. (Pubitemid 21908985)
-
(1991)
Journal of Biological Chemistry
, vol.266
, Issue.36
, pp. 24613-24620
-
-
Subramaniam, A.1
Jones, W.K.2
Gulick, J.3
Wert, S.4
Neumann, J.5
Robbins, J.6
-
11
-
-
76749101817
-
Renin-angiotensin system in kidney development: Renal tubular dysgenesis
-
Gubler MC, Antignac C. Renin-angiotensin system in kidney development: renal tubular dysgenesis. Kidney Int. 2010;77:400-406.
-
(2010)
Kidney Int.
, vol.77
, pp. 400-406
-
-
Gubler, M.C.1
Antignac, C.2
-
12
-
-
0037462643
-
Brain-specific restoration of angiotensin II corrects renal defects seen in angiotensinogen-deficient mice
-
DOI 10.1074/jbc.M209933200
-
Lochard N, Silversides DW, Van Kats JP, Mercure C, Reudelhuber TL. Brain-specific restoration of angiotensin II corrects renal defects seen in angiotensinogen-deficient mice. J Biol Chem. 2003;278:2184-2189. (Pubitemid 36801284)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.4
, pp. 2184-2189
-
-
Lochard, N.1
Silversides, D.W.2
Van Kats, J.P.3
Mercure, C.4
Reudelhuber, T.L.5
-
13
-
-
15444367989
-
The renin-angiotensin system: Peptides and enzymes beyond angiotensin II
-
Reudelhuber TL. The renin-angiotensin system: peptides and enzymes beyond angiotensin II. Curr Opin Nephrol Hypertens. 2005;14:155-159. (Pubitemid 40396869)
-
(2005)
Current Opinion in Nephrology and Hypertension
, vol.14
, Issue.2
, pp. 155-159
-
-
Reudelhuber, T.L.1
-
14
-
-
2942659879
-
Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist
-
DOI 10.1161/01.RES.0000130654.56599.40
-
Lochard N, Thibault G, Silversides DW, Touyz RM, Reudelhuber TL. Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist. Circ Res. 2004;94:1451-1457. (Pubitemid 38780317)
-
(2004)
Circulation Research
, vol.94
, Issue.11
, pp. 1451-1457
-
-
Lochard, N.1
Thibault, G.2
Silversides, D.W.3
Touyz, R.M.4
Reudelhuber, T.L.5
-
15
-
-
43049157967
-
Angiotensin-(1-7): Pharmacological properties and pharmacotherapeutic perspectives
-
Iusuf D, Henning RH, Van Gilst WH, Roks AJ. Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives. Eur J Pharmacol. 2008;585:303-312.
-
(2008)
Eur J Pharmacol
, vol.585
, pp. 303-312
-
-
Iusuf, D.1
Henning, R.H.2
Van Gilst, W.H.3
Roks, A.J.4
-
16
-
-
33646153057
-
A place in our hearts for the lowly angiotensin 1-7 peptide?
-
DOI 10.1161/01.HYP.0000209020.69734.73, PII 0000426820060500000002
-
Reudelhuber TL. A place in our hearts for the lowly angiotensin 1-7 peptide? Hypertension. 2006;47:811-815. (Pubitemid 44297545)
-
(2006)
Hypertension
, vol.47
, Issue.5
, pp. 811-815
-
-
Reudelhuber, T.L.1
-
17
-
-
0037142101
-
Angiotensin-converting enzyme 2 is an essential regulator of heart function
-
DOI 10.1038/nature00786
-
Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos AJ, da CJ, Zhang L, Pei Y, Scholey J, Ferrario CM, Manoukian AS, Chappell MC, Backx PH, Yagil Y, Penninger JM. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417:822-828. (Pubitemid 34670323)
-
(2002)
Nature
, vol.417
, Issue.6891
, pp. 822-828
-
-
Crackower, M.A.1
Sarao, R.2
Oudit, G.Y.3
Yagil, C.4
Kozieradzki, I.5
Scanga, S.E.6
Oliveira-Dos-Santos, A.J.7
Da Costa, J.8
Zhang, L.9
Pei, Y.10
Scholey, J.11
Ferrarlo, C.M.12
Manoukian, A.S.13
Chappell, M.C.14
Backx, P.H.15
Yagil, Y.16
Penninger, J.M.17
-
18
-
-
3042723695
-
Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats
-
DOI 10.1152/physiolgenomics.00227.2003
-
Santos RA, Ferreira AJ, Nadu AP, Braga AN, de Almeida AP, Campagnole-Santos MJ, Baltatu O, Iliescu R, Reudelhuber TL, Bader M. Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats. Physiol Genomics. 2004;17:292-299. (Pubitemid 38924174)
-
(2004)
Physiological Genomics
, vol.17
, pp. 292-299
-
-
Santos, R.A.S.1
Ferreira, A.J.2
Nadu, A.P.3
Braga, A.N.G.4
De Almeida, A.P.5
Campagnole-Santos, M.J.6
Baltatu, O.7
Iliescu, R.8
Reudelhuber, T.L.9
Bader, M.10
-
19
-
-
34250794999
-
Expression of an angiotensin-(1-7)-producing fusion protein in rats induced marked changes in regional vascular resistance
-
DOI 10.1152/ajpheart.01245.2006
-
Botelho-Santos GA, Sampaio WO, Reudelhuber TL, Bader M, Campagnole-Santos MJ, Souza dos Santos RA. Expression of an angiotensin-( 1-7)-producing fusion protein in rats induced marked changes in regional vascular resistance. Am J Physiol Heart Circ Physiol. 2007;292: H2485-H2490. (Pubitemid 47084632)
-
(2007)
American Journal of Physiology - Heart and Circulatory Physiology
, vol.292
, Issue.5
-
-
Botelho-Santos, G.A.1
Sampaio, W.O.2
Reudelhuber, T.L.3
Bader, M.4
Campagnole-Santos, M.J.5
Dos Santos, R.A.S.6
-
20
-
-
33751503376
-
Renal function in transgenic rats expressing an angiotensin-(1-7)- producing fusion protein
-
DOI 10.1016/j.regpep.2006.06.005, PII S0167011506000966
-
Ferreira AJ, Pinheiro SV, Castro CH, Silva GA, Silva AC, Almeida AP, Bader M, Rentzsch B, Reudelhuber TL, Santos RA. Renal function in transgenic rats expressing an angiotensin-(1-7)-producing fusion protein. Regul Pept. 2006;137:128-133. (Pubitemid 44838976)
-
(2006)
Regulatory Peptides
, vol.137
, Issue.3
, pp. 128-133
-
-
Ferreira, A.J.1
Pinheiro, S.V.B.2
Castro, C.H.3
Silva, G.A.B.4
Simoes Silva, A.C.5
Almeida, A.P.6
Bader, M.7
Rentzsch, B.8
Reudelhuber, T.L.9
Santos, R.A.S.10
-
21
-
-
58149352445
-
Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart
-
Mercure C, Yogi A, Callera GE, Aranha AB, Bader M, Ferreira AJ, Santos RA, Walther T, Touyz RM, Reudelhuber TL. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ Res. 2008;103:1319-1326.
-
(2008)
Circ Res
, vol.103
, pp. 1319-1326
-
-
Mercure, C.1
Yogi, A.2
Callera, G.E.3
Aranha, A.B.4
Bader, M.5
Ferreira, A.J.6
Santos, R.A.7
Walther, T.8
Touyz, R.M.9
Reudelhuber, T.L.10
-
22
-
-
77950497363
-
Attenuation of isoproterenol-induced cardiac fibrosis in transgenic rats harboring an angiotensin-(1-7)-producing fusion protein in the heart
-
Ferreira AJ, Castro CH, Guatimosim S, Almeida PW, Gomes ER, as-Peixoto MF, Alves MN, Fagundes-Moura CR, Rentzsch B, Gava E, Almeida AP, Guimaraes AM, Kitten GT, Reudelhuber T, Bader M, Santos RA. Attenuation of isoproterenol-induced cardiac fibrosis in transgenic rats harboring an angiotensin-(1-7)-producing fusion protein in the heart. Ther Adv Cardiovasc Dis. 2010;4:83-96.
-
(2010)
Ther Adv Cardiovasc Dis
, vol.4
, pp. 83-96
-
-
Ferreira, A.J.1
Castro, C.H.2
Guatimosim, S.3
Almeida, P.W.4
Gomes, E.R.5
As-Peixoto, M.F.6
Alves, M.N.7
Fagundes-Moura, C.R.8
Rentzsch, B.9
Gava, E.10
Almeida, A.P.11
Guimaraes, A.M.12
Kitten, G.T.13
Reudelhuber, T.14
Bader, M.15
Santos, R.A.16
-
23
-
-
78049352553
-
The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension
-
Shenoy V, Ferreira AJ, Qi Y, Fraga-Silva RA, ez-Freire C, Dooies A, Jun JY, Sriramula S, Mariappan N, Pourang D, Venugopal CS, Francis J, Reudelhuber T, Santos RA, Patel JM, Raizada MK, Katovich MJ. The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med. 2010;182:1065-1072.
-
(2010)
Am J Respir Crit Care Med
, vol.182
, pp. 1065-1072
-
-
Shenoy, V.1
Ferreira, A.J.2
Qi, Y.3
Fraga-Silva, R.A.4
Ez-Freire, C.5
Dooies, A.6
Jun, J.Y.7
Sriramula, S.8
Mariappan, N.9
Pourang, D.10
Venugopal, C.S.11
Francis, J.12
Reudelhuber, T.13
Santos, R.A.14
Patel, J.M.15
Raizada, M.K.16
Katovich, M.J.17
-
24
-
-
0035941213
-
Use of a biological peptide pump to study chronic peptide hormone action in transgenic mice. Direct and indirect effects of angiotensin II on the heart
-
Van Kats JP, Methot D, Paradis P, Silversides DW, Reudelhuber TL. Use of a biological peptide pump to study chronic peptide hormone action in transgenic mice. Direct and indirect effects of angiotensin II on the heart. J Biol Chem. 2001;276:44012-44017.
-
(2001)
J Biol Chem
, vol.276
, pp. 44012-44017
-
-
Van Kats, J.P.1
Methot, D.2
Paradis, P.3
Silversides, D.W.4
Reudelhuber, T.L.5
-
25
-
-
34548415025
-
Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction
-
DOI 10.1152/ajpheart.00379.2007
-
Xu J, Carretero OA, Lin CX, Cavasin MA, Shesely EG, Yang JJ, Reudelhuber TL, Yang XP. Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction. Am J Physiol Heart Circ Physiol. 2007;293:H1900-H1907. (Pubitemid 47367241)
-
(2007)
American Journal of Physiology - Heart and Circulatory Physiology
, vol.293
, Issue.3
-
-
Xu, J.1
Carretero, O.A.2
Lin, C.-X.3
Cavasin, M.A.4
Shesely, E.G.5
Yang, J.J.6
Reudelhuber, T.L.7
Yang, X.-P.8
-
26
-
-
78249242127
-
Local angiotensin II aggravates cardiac remodeling in hypertension
-
Xu J, Carretero OA, Liao TD, Peng H, Shesely EG, Xu J, Liu TS, Yang JJ, Reudelhuber TL, Yang XP. Local angiotensin II aggravates cardiac remodeling in hypertension. Am J Physiol Heart Circ Physiol. 2010;299: H1328-H1338.
-
(2010)
Am J Physiol Heart Circ Physiol.
, vol.299
-
-
Xu, J.1
Carretero, O.A.2
Liao, T.D.3
Peng, H.4
Shesely, E.G.5
Xu, J.6
Liu, T.S.7
Yang, J.J.8
Reudelhuber, T.L.9
Yang, X.P.10
-
27
-
-
0034688194
-
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
-
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-153.
-
(2000)
N Engl J Med
, vol.342
, pp. 145-153
-
-
Yusuf, S.1
Sleight, P.2
Pogue, J.3
Bosch, J.4
Davies, R.5
Dagenais, G.6
-
28
-
-
0037160968
-
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
-
DOI 10.1016/S0140-6736(02)08089-3
-
Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:995-1003. (Pubitemid 34286536)
-
(2002)
Lancet
, vol.359
, Issue.9311
, pp. 995-1003
-
-
Dahlof, B.1
Devereux, R.B.2
Kjeldsen, S.E.3
Julius, S.4
Beevers, G.5
De Faire, U.6
Fyhrquist, F.7
Ibsen, H.8
Kristiansson, K.9
Lederballe-Pedersen, O.10
Lindholm, L.H.11
Nieminen, M.S.12
Omvik, P.13
Oparil, S.14
Wedel, H.15
-
29
-
-
0042410539
-
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-overall programme
-
DOI 10.1016/S0140-6736(03)14282-1
-
Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003;362:759-766. (Pubitemid 37093915)
-
(2003)
Lancet
, vol.362
, Issue.9386
, pp. 759-766
-
-
Pfeffer, M.A.1
Swedberg, K.2
Granger, C.B.3
Held, P.4
McMurray, J.J.V.5
Michelson, E.L.6
Olofsson, B.7
Ostergren, J.8
Yusuf, S.9
|